In 1763 adults having cancer resection, propofol vs volatile anaesthesia did not improve survival (deaths 26.1% vs 22.9%; HR 1.16, non-significant). In the per-protocol population (n=1411), more propofol patients died (25.5% vs 20%).
RCTn = 1,766
Bennett-Guerrero et al. Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial